Zymeworks
ZYME
164 hedge funds and large institutions have $581M invested in Zymeworks in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 54 reducing their positions, and 28 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 54
0.44% more ownership
Funds ownership: 96.05% → 96.48% (+0.44%)
4% less funds holding
Funds holding: 171 → 164 (-7)
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
19% less capital invested
Capital invested by funds: $713M → $581M (-$132M)
57% less call options, than puts
Call options by funds: $496K | Put options by funds: $1.15M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$16.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.1M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$6.85M |
| 4 |
PA
Perceptive Advisors
New York
|
+$5.28M |
| 5 |
SCM
Sio Capital Management
New York
|
+$4.37M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$7.76M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.15M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$6.12M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.14M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$4.08M |
ZYME Hedge Fund Activity: Q2 2024 in Review
164 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2024, worth a combined $581M — down 19% from $713M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ZYME and 24 opened new positions — a net loss of 4 holders — while 54 trimmed existing stakes and 59 added.
The largest buyer was UBS AM, adding an estimated $16.4M. The largest seller was Morgan Stanley, cutting an estimated $7.76M.
- 164 institutional investors held Zymeworks (ZYME) as of Q2 2024, down from 171 in Q1 2024.
- Funds reported $581M of Zymeworks stock for Q2 2024, down 19% quarter-over-quarter.
- 24 funds opened new Zymeworks positions in Q2 2024 and 28 closed out, a net change of -4 holders.
- The largest Zymeworks buyer in Q2 2024 was UBS AM, an estimated $16.4M added.
- The largest Zymeworks seller in Q2 2024 was Morgan Stanley, an estimated $7.76M sold.
Based on aggregated 13F filings for Q2 2024.